Investing.com - Takeda Pharma ADR reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Takeda Pharma ADR announced earnings per share of ¥0.2477 on revenue of ¥7.08B. Analysts polled by Investing.com anticipated EPS of ¥0.2417 on revenue of ¥6.92B.
Takeda Pharma ADR shares are up 7.78% from the beginning of the year, still down 15.14% from its 52 week high of ¥17.31 set on September 21, 2021. They are outperforming the EUR/USD which is down 0% from the start of the year.
Takeda Pharma ADR shares lost 0.03% in intra-day trade following the report.
Takeda Pharma ADR follows other major Healthcare sector earnings this month
Takeda Pharma ADR's report follows an earnings beat by UnitedHealth on July 15, who reported EPS of ¥5.57 on revenue of ¥80.33B, compared to forecasts EPS of ¥5.21 on revenue of ¥79.68B.
J&J had beat expectations on July 19 with second quarter EPS of ¥2.59 on revenue of ¥24.02B, compared to forecast for EPS of ¥2.54 on revenue of ¥23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar